Elicio Therapeutics
Transforming the lives of patients and their families by re-engineering the body’s immune response to cancer. Learn more
Launch date
Employees
Market cap
AUD69.7m
Enterprise valuation
AUD74m (Public information from Sep 2024)
Share price
$5.07 ELTX
Cambridge Massachusetts (HQ)
Authorizing premium user...